Study tumor metabolism in certain types of breast cancer surgery
Part of Cancer, Skin clinical trials.
This study looks at how breast cancer cells use energy and nutrients in hormone-receptor positive, HER2-negative tumors during planned surgery. It may help researchers understand the cancer better by comparing tumor tissue with nearby normal tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your breast cancer is hormone-receptor positive and HER2 negative (ER and/or PR positive, but not HER2+).
- Your cancer stage is early (stage I, II, or III).
- You are planning curative surgery (tumor removal) and you have NOT had neoadjuvant treatment before surgery (no chemo, immunotherapy, or hormone therapy before the operation).
- You can safely provide extra small tissue samples during surgery (small biopsies of tumor and normal tissue, typically 4–6 passes).
- You are not in another research study that gives treatments during the same time period.
- If you could become pregnant, you can provide a recent negative pregnancy test done outside of this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your metabolism (things like blood sugar and cholesterol) might be linked to tumor genes and growth in people with breast cancer. The goal is to find new ways to treat the disease based on your metabolic profile. You may be eligible if you have locally advanced breast cancer (Stage II–III) and are willing to share your medical records.
This study collects fresh breast-tissue biopsies from people with newly diagnosed breast cancer to learn more about how their bodies’ metabolism may affect the cancer. If you qualify, you may be asked to provide tissue samples before starting certain cancer treatments.
This trial looks at different drug combinations given before surgery to shrink breast tumors. The goal is to find which treatments work best for different types of breast cancer, such as triple-negative, HER2-positive, or hormone-receptor-positive. If you are a woman scheduled for neoadjuvant therapy (treatment before surgery) and have not had previous cancer treatment, this study may be for you.
This Phase 2 study looks at how well early breast cancer shrinks with treatment and how that matches with what doctors find after surgery under the microscope. The goal is to learn better ways to predict and assess treatment success.
This study tests whether using PET scans (a special imaging technique) to monitor how your HER2-positive breast cancer responds to treatment before surgery can help doctors choose the best treatment plan for you. The goal is to improve outcomes by personalizing therapy based on how your tumor responds.
This trial tests new treatment given before surgery for certain stage IIb–IIIc breast cancers. It uses results from your tumor to guide the treatment plan and aims to improve how well the therapy works before the operation.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.